SRPT   $127.28  0.14% Market Closed After Close 128.1568 0.69%

Sarepta Therapeutics Inc
Total Cash 1.46B
totalCashPerShare 15.314
EBITDA 77.75M
Total Debt 1.39B
quickRatio 2.691
currentRatio 3.898
Total Revenue 1.50B
debtToEquity 128.779
Revenue/Share 15.789
ROA 0.0072500003
ROE 0.052020002
grossProfits
freeCashflow -408.09M
operatingCashflow -396.50M
earningsGrowth
revenueGrowth 0.389
grossMargins 0.37129003
ebitdaMargins 0.051659998
operatingMargins -0.00193
profitMargins 0.03143
enterpriseValue 11.81B
forwardPE 11.404391
floatShares 91.00M
sharesOutstanding 95.37M
sharesShort 6.53M
sharesShortPriorMonth 6.72M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.94%
Short Ratio help_outline 5.71%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 11.304
Price To Book help_outline 11.03
earningsQuarterlyGrowth
netIncomeToCommon 47.30M
trailingEps 0.75%
forwardEps 10.93%
enterpriseToEbitda 151.95
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.14 3Q 2024
institutionsCount 675
lastUpdated Sept. 16, 2024, 12:37 p.m.